KalVista Pharmaceuticals, Inc. (KALV)

26.77 +0.01 (+0.04%) USD  |  NASDAQ  |  May 19, 16:00
26.76 -0.01 (-0.04%) Pre-Market: 08:54
More

KalVista Pharmaceuticals Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Sensei Biotherapeutics, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade